Wall Street brokerages expect Morgan Stanley (NYSE: MS – Get Rating) to announce sales of $ 14.18 billion for the current quarter, Zacks reports. Four analysts have issued estimates for Morgan Stanley’s earnings, with the lowest sales estimate coming in at $ 14.00 billion and the highest estimate coming in at $ 14.43 billion. Morgan Stanley posted sales of $ 14.76 billion during the same quarter last year, which suggests a negative year over year growth rate of 3.9%. The business is expected to report its next earnings report on Monday, January 1st.
On average, analysts expect that Morgan Stanley will report full-year sales of $ 57.66 billion for the current financial year, with estimates ranging from $ 56.98 billion to $ 58.60 billion. For the next year, analysts expect that the company will post sales of $ 60.76 billion, with estimates ranging from $ 60.16 billion to $ 62.38 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Morgan Stanley.
Morgan Stanley (NYSE: MS – Get Rating) last announced its quarterly earnings results on Thursday, April 14th. The financial services provider reported $ 2.06 earnings per share for the quarter, beating the consensus estimate of $ 1.69 by $ 0.37. Morgan Stanley had a return on equity of 15.15% and a net margin of 24.21%. The firm had revenue of $ 14.80 billion during the quarter, compared to analyst estimates of $ 14.16 billion. During the same quarter in the previous year, the business earned $ 2.22 EPS. Morgan Stanley’s revenue for the quarter was down 5.8% compared to the same quarter last year.
A number of equities research analysts recently commented on the stock. BMO Capital Markets raised their price objective on shares of Morgan Stanley from $ 110.00 to $ 113.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. Wells Fargo & Company dropped their price objective on shares of Morgan Stanley from $ 104.00 to $ 94.00 and set an “equal weight” rating for the company in a research note on Monday, April 4th. Piper Sandler lowered their target price on shares of Morgan Stanley from $ 112.00 to $ 100.00 and set a “neutral” rating for the company in a research note on Tuesday, April 5th. StockNews.com began coverage on shares of Morgan Stanley in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Finally, Oppenheimer upgraded shares of Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $ 111.00 price target on the stock in a report on Tuesday, May 3rd. Twelve equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $ 107.06.
NYSE: MS opened at $ 80.54 on Friday. The firm has a market capitalization of $ 140.89 billion, a PE ratio of 10.25, a price-to-earnings-growth ratio of 1.34 and a beta of 1.42. The business’s fifty day moving average price is $ 86.38 and its 200 day moving average price is $ 94.75. The company has a debt-to-equity ratio of 2.39, a current ratio of 0.79 and a quick ratio of 0.79. Morgan Stanley has a 12 month low of $ 76.75 and a 12 month high of $ 109.73.
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 13th. Investors of record on Friday, April 29th were paid a dividend of $ 0.70 per share. This represents a $ 2.80 annualized dividend and a yield of 3.48%. The ex-dividend date of this dividend was Thursday, April 28th. Morgan Stanley’s payout ratio is 35.62%.
In related news, Director Stephen J. Luczo bought 25,000 shares of the company’s stock in a transaction on Thursday, May 12th. The shares were purchased at an average cost of $ 79.30 per share, for a total transaction of $ 1,982,500.00. Following the acquisition, the director now owns 179,449 shares of the company’s stock, valued at approximately $ 14,230,305.70. The purchase was disclosed in a filing with the SEC, which is available at this link. 0.26% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of MS. JFS Wealth Advisors LLC grew its position in shares of Morgan Stanley by 61.6% during the 4th quarter. JFS Wealth Advisors LLC now owns 265 shares of the financial services provider’s stock worth $ 26,000 after purchasing an additional 101 shares in the last quarter. Legacy Financial Advisors Inc. boosted its position in shares of Morgan Stanley by 2.3% during the 4th quarter. Legacy Financial Advisors Inc. now owns 4,562 shares of the financial services provider’s stock worth $ 448,000 after acquiring an additional 102 shares in the last quarter. Johnson Financial Group Inc. boosted its position in shares of Morgan Stanley by 1.2% during the 4th quarter. Johnson Financial Group Inc. now owns 8,714 shares of the financial services provider’s stock worth $ 855,000 after acquiring an additional 102 shares in the last quarter. North Star Investment Management Corp. boosted its position in shares of Morgan Stanley by 2.0% during the 4th quarter. North Star Investment Management Corp. now owns 5,230 shares of the financial services provider’s stock worth $ 513,000 after acquiring an additional 104 shares in the last quarter. Finally, Jackson Square Capital LLC boosted its position in shares of Morgan Stanley by 2.2% during the 1st quarter. Jackson Square Capital LLC now owns 5,167 shares of the financial services provider’s stock worth $ 452,000 after acquiring an additional 112 shares in the last quarter. Institutional investors and hedge funds own 85.02% of the company’s stock.
About Morgan Stanley (Get Rating)
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Get a free copy of the Zacks research report on Morgan Stanley (MS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Morgan Stanley right now?
Before you consider Morgan Stanley, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on … and Morgan Stanley wasn’t on the list.
While Morgan Stanley currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here